Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
PaperCitations, authors & open-access status
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 493 citations, 2022 year and hybrid oa status.
493
Citations
2022
Year
hybrid
OA Status